“…As reported in a few prospective randomized studies, the use of PLGM in T1D significantly reduced hypoglycemic events, including severe hypoglycemia [7] , [19] , [20] . We found a downward trend in TBR over the 3 years of follow-up in all groups, with a statistically significant decrease in patients who switched to the 640G system at baseline and in those with severe hypoglycemia before PLGM use.…”